Umami Bioworks Marine Cell Cultivation Delivers PDRN Without Reliance on Salmon Sperm Harvesting
Singapore-based biotechnology company Umami Bioworks has introduced Marine Radiance™, a platform for developing marine-derived bioactives, and announced what it says is the world’s first animal‑free polydeoxyribonucleotide (PDRN) for use across skincare and medical applications. PDRN, a compound used in anti-aging skincare, wound healing, and regenerative medicine, is currently sourced from salmon sperm. This conventional method involves transporting salmon reproductive organs across global supply chains, a process that raises logistical, ethical, …
ÄIO Awarded €1M for Development of Yeast-Based Oils for Cosmetics Applications
Estonian biotechnology firm ÄIO has secured €1 million in government-backed funding to develop and scale up microbial fermentation-based oils for use in cosmetics and chemical applications. The funding was awarded through Estonia’s Applied Research Programme (RUP), which is managed by the Estonian Business and Innovation Agency (EIS). The grant supports a three-year R&D initiative focused on the development of fermentation-derived lipids and derivatives as substitutes for conventional oils such as …
Avant’s Zellulin Cell-Cultured Peptide Becomes First Non-Food Product to Earn C-Label Certification
Avant’s Zellulin® ZelluGEN™ has achieved a milestone in the growing field of cellular agriculture by becoming the first non-food product to receive the C-Label certification. The C-Label, created by V-Label, is a standard that aims to ensure transparency and ethical practices in products derived from cellular agriculture. Zellulin® ZelluGEN™, a multi-peptide complex derived from fish cells, is produced through cell cultivation rather than traditional animal sourcing, positioning it as a …